Patient Square Capital

Latest statistics and disclosures from Patient Square Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ROIV, LQDA, CGEM, INSM, EYPT, and represent 92.86% of Patient Square Capital's stock portfolio.
  • Added to shares of these 9 stocks: CGEM (+$14M), INSM (+$13M), EYPT (+$11M), NRIX (+$7.3M), PHVS, NTLA, ELVN, OCUL, ATXS.
  • Started 9 new stock positions in CGEM, INSM, EYPT, ELVN, OCUL, ATXS, NTLA, PHVS, NRIX.
  • Patient Square Capital was a net buyer of stock by $57M.
  • Patient Square Capital has $269M in assets under management (AUM), dropping by 14.73%.
  • Central Index Key (CIK): 0001819257

Tip: Access up to 7 years of quarterly data

Positions held by Patient Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Patient Square Capital

Patient Square Capital holds 11 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Roivant Sciences SHS (ROIV) 52.4 $141M 12M 11.54
 View chart
Liquidia Corporation Com New (LQDA) 26.7 $72M 7.2M 10.00
 View chart
Cullinan Oncology (CGEM) 5.1 $14M NEW 825k 16.74
 View chart
Insmed Com Par $.01 (INSM) 4.7 $13M NEW 172k 73.00
 View chart
Eyepoint Pharmaceuticals Com New (EYPT) 4.0 $11M NEW 1.4M 7.99
 View chart
Nurix Therapeutics (NRIX) 2.7 $7.3M NEW 326k 22.47
 View chart
Pharvaris N V (PHVS) 1.7 $4.5M NEW 242k 18.52
 View chart
Intellia Therapeutics (NTLA) 1.0 $2.6M NEW 129k 20.55
 View chart
Enliven Therapeutics (ELVN) 0.9 $2.3M NEW 91k 25.54
 View chart
Ocular Therapeutix (OCUL) 0.8 $2.0M NEW 236k 8.70
 View chart
Astria Therapeutics (ATXS) 0.2 $434k NEW 39k 11.01
 View chart

Past Filings by Patient Square Capital

SEC 13F filings are viewable for Patient Square Capital going back to 2022